Literature DB >> 31865627

Importance of family history and indications for genetic testing.

Marie E Wood1, Hibba Tul Rehman1, Isabelle Bedrosian2.   

Abstract

Family history is an important cancer risk assessment tool, and it is easy to use. The family history is integral in identifying an individual's risk for primary cancer and assists in the assessment of risk for a second primary cancer. For oncology providers, the critical family history is defined as including first- and second-degree family history, maternal and paternal history, type of primary cancer, and age at diagnosis and ethnicity. Family history should be taken at diagnosis and updated periodically. Despite the importance of family history to patient care, there are significant barriers to taking a family history. We review the impact of collecting complete family history data with respect to calculation of cancer risk, recommendations for screening, and prevention strategies and referral for genetic testing.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  cancer family history; genetics; prevention; screening

Mesh:

Year:  2019        PMID: 31865627     DOI: 10.1111/tbj.13722

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  4 in total

1.  Family history of malignant tumor is a predictor of gastric cancer prognosis: Incorporation into a nomogram.

Authors:  Fanke Wang; Liqiao Fan; Qun Zhao; Yu Liu; Zhidong Zhang; Dong Wang; Xuefeng Zhao; Yong Li; Bibo Tan
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

2.  Association of Family History with the Development of Breast Cancer: A Cohort Study of 129,374 Women in KoGES Data.

Authors:  Hyo Geun Choi; Jung Ho Park; Yeon Ju Choi; Yong Joon Suh
Journal:  Int J Environ Res Public Health       Date:  2021-06-13       Impact factor: 3.390

3.  Cancer Previvors in an Active Duty Service Women Population: An Opportunity for Prevention and Increased Force Readiness.

Authors:  Leann A Lovejoy; Clesson E Turner; Craig D Shriver; Rachel E Ellsworth
Journal:  Mil Med       Date:  2021-07-01       Impact factor: 1.437

4.  Diagnosis and treatment of uterine sarcoma: A multicenter, real-world study in western China.

Authors:  Kemin Li; Rutie Yin; Li Li; Danqing Wang; Li Li; Cailing Ma; Qianchuan Ren; Guqing Wang; Yang Fan; Honggui Zhou; Zi Liu; Tao Li; Kunrong Luo; Dingqing Kui; Jingyi Wang
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.